Resources

Jun 16, 2026

CSRxP: HELP Preview Biosimilar Fact Sheet

Several bipartisan, market-based solutions that would help foster greater

Jun 12, 2026

CSRxP: HELP Markup Fact Sheet

How Congress Can Lower Drug Prices, Boost Competition  Trio of Bipartisan

Jun 11, 2026

CSRxP: Myth vs. Fact

Brand name drug manufacturers game the patent system and drug approval process

Jun 1, 2026

Infographic: ETHIC & Skinny Labels

Two bipartisan solutions — the ETHIC Act and Skinny Labels

May 29, 2026

CSRxP: Innovation

For far too long, Big Pharma has used the false excuse that research and

Feb 10, 2026

CSRxP: Statement for the Record

Committee Chairman Guthrie, Committee Ranking Member Pallone, Subcommittee

Jan 20, 2026

CSRxP: Affordability

Big Pharma’s egregious pricing and anti-competitive practices are

Jan 13, 2026

CSRxP: Margin Analysis

Pharmaceutical manufacturers’ profit margins are 10 times larger than other

Apr 28, 2025

Patent Abuserol

Apr 28, 2025

Max Profitrexil

Apr 28, 2025

CSRxP DTC ADVERTISING CAMPAIGN

The Campaign for Sustainable Rx Pricing (CSRxP) announced the launch of a new

Apr 7, 2025

Fact Sheet: Biosimilar Competition

Big Pharma deploys a full suite of tactics designed to game the U.S. patent